Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 308

1.

Adjuvant chemotherapy with doxorubicin and dacarbazine has no effect in recurrence-free survival of malignant phyllodes tumors of the breast.

Morales-Vásquez F, Gonzalez-Angulo AM, Broglio K, Lopez-Basave HN, Gallardo D, Hortobagyi GN, De La Garza JG.

Breast J. 2007 Nov-Dec;13(6):551-6.

PMID:
17983394
[PubMed - indexed for MEDLINE]
2.

Doxorubicin-based adjuvant chemotherapy in elderly breast cancer patients: the M.D. Anderson experience, with long-term follow-up.

Ibrahim NK, Buzdar AU, Asmar L, Theriault RL, Hortobagyi GN.

Ann Oncol. 2000 Dec;11(12):1597-601.

PMID:
11205469
[PubMed - indexed for MEDLINE]
Free Article
4.

Efficacy of adjuvant CYVADIC chemotherapy in early-stage uterine sarcomas: results of long-term follow-up.

Odunsi K, Moneke V, Tammela J, Ghamande S, Seago P, Driscoll D, Marchetti D, Baker T, Lele S.

Int J Gynecol Cancer. 2004 Jul-Aug;14(4):659-64.

PMID:
15304162
[PubMed - indexed for MEDLINE]
5.

Phyllodes tumor of the breast: stromal overgrowth and histological classification are useful prognosis-predictive factors for local recurrence in patients with a positive surgical margin.

Taira N, Takabatake D, Aogi K, Ohsumi S, Takashima S, Nishimura R, Teramoto N.

Jpn J Clin Oncol. 2007 Oct;37(10):730-6. Epub 2007 Oct 11.

PMID:
17932112
[PubMed - indexed for MEDLINE]
Free Article
6.

The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.

Garside R, Pitt M, Anderson R, Rogers G, Dyer M, Mealing S, Somerville M, Price A, Stein K.

Health Technol Assess. 2007 Nov;11(45):iii-iv, ix-221. Review.

PMID:
17999840
[PubMed - indexed for MEDLINE]
Free Article
7.

17-year follow-up of a randomized prospective controlled trial of adjuvant intravesical doxorubicin in the treatment of superficial bladder cancer.

Cheng CW, Chan PS, Chan LW, Chan CK, Ng CF, Lai MM.

Int Braz J Urol. 2005 May-Jun;31(3):204-11.

PMID:
15992422
[PubMed - indexed for MEDLINE]
Free Article
9.

Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18.

Fisher B, Brown A, Mamounas E, Wieand S, Robidoux A, Margolese RG, Cruz AB Jr, Fisher ER, Wickerham DL, Wolmark N, DeCillis A, Hoehn JL, Lees AW, Dimitrov NV.

J Clin Oncol. 1997 Jul;15(7):2483-93.

PMID:
9215816
[PubMed - indexed for MEDLINE]
10.

Predictive factors of local recurrence and survival following primary surgical treatment of phyllodes tumors of the breast.

Abdalla HM, Sakr MA.

J Egypt Natl Canc Inst. 2006 Jun;18(2):125-33.

PMID:
17496937
[PubMed - indexed for MEDLINE]
Free Article
11.

[Analysis of the treatment and prognosis of recurrent breast phyllodes tumor].

Fang Y, Gao JD, Tian YT, Xie YQ, Zhen S.

Zhonghua Zhong Liu Za Zhi. 2009 Jan;31(1):72-4. Chinese.

PMID:
19538877
[PubMed - indexed for MEDLINE]
12.

A prospective, multi-institutional study of adjuvant radiotherapy after resection of malignant phyllodes tumors.

Barth RJ Jr, Wells WA, Mitchell SE, Cole BF.

Ann Surg Oncol. 2009 Aug;16(8):2288-94. doi: 10.1245/s10434-009-0489-2. Epub 2009 May 8.

PMID:
19424757
[PubMed - indexed for MEDLINE]
13.

Phyllodes tumors of the breast: a review of 32 cases.

Geisler DP, Boyle MJ, Malnar KF, McGee JM, Nolen MC, Fortner SM, Broughan TA.

Am Surg. 2000 Apr;66(4):360-6.

PMID:
10776873
[PubMed - indexed for MEDLINE]
14.

Overview of resistance to systemic therapy in patients with breast cancer.

Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN.

Adv Exp Med Biol. 2007;608:1-22. Review.

PMID:
17993229
[PubMed - indexed for MEDLINE]
15.

Management of phyllodes breast tumors.

Guillot E, Couturaud B, Reyal F, Curnier A, Ravinet J, Laé M, Bollet M, Pierga JY, Salmon R, Fitoussi A; Breast Cancer Study Group of the Institut Curie.

Breast J. 2011 Mar-Apr;17(2):129-37. doi: 10.1111/j.1524-4741.2010.01045.x. Epub 2011 Jan 19.

PMID:
21251125
[PubMed - indexed for MEDLINE]
16.

Phyllodes tumor of the breast.

Belkacémi Y, Bousquet G, Marsiglia H, Ray-Coquard I, Magné N, Malard Y, Lacroix M, Gutierrez C, Senkus E, Christie D, Drumea K, Lagneau E, Kadish SP, Scandolaro L, Azria D, Ozsahin M.

Int J Radiat Oncol Biol Phys. 2008 Feb 1;70(2):492-500. Epub 2007 Oct 10.

PMID:
17931796
[PubMed - indexed for MEDLINE]
17.

Clinical significance of axillary nodal ratio in stage II/III breast cancer treated with neoadjuvant chemotherapy.

Keam B, Im SA, Kim HJ, Oh DY, Kim JH, Lee SH, Chie EK, Han W, Kim DW, Cho N, Moon WK, Kim TY, Park IA, Noh DY, Heo DS, Ha SW, Bang YJ.

Breast Cancer Res Treat. 2009 Jul;116(1):153-60. doi: 10.1007/s10549-008-0160-9. Epub 2008 Sep 12.

PMID:
18787948
[PubMed - indexed for MEDLINE]
18.

Clinical outcome of concomitant chemoradiotherapy followed by adjuvant temozolomide therapy for glioblastaomas: single-center experience.

Jeon HJ, Kong DS, Park KB, Lee JI, Park K, Kim JH, Kim ST, Lim do H, Kim WS, Nam DH.

Clin Neurol Neurosurg. 2009 Oct;111(8):679-82. doi: 10.1016/j.clineuro.2009.06.013. Epub 2009 Jul 28.

PMID:
19640635
[PubMed - indexed for MEDLINE]
19.

Retrospective analysis of 25 women with malignant cystosarcoma phyllodes--treatment results.

Soumarová R, Seneklová Z, Horová H, Vojkovská H, Horová I, Budíková M, Růzicková J, Jezková B.

Arch Gynecol Obstet. 2004 May;269(4):278-81. Epub 2004 Mar 6.

PMID:
15205980
[PubMed - indexed for MEDLINE]
20.

Ten-year outcomes in a population-based cohort of node-negative, lymphatic, and vascular invasion-negative early breast cancers without adjuvant systemic therapies.

Chia SK, Speers CH, Bryce CJ, Hayes MM, Olivotto IA.

J Clin Oncol. 2004 May 1;22(9):1630-7.

PMID:
15117985
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk